136 related articles for article (PubMed ID: 15914206)
41. Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression.
Shahrzad S; Quayle L; Stone C; Plumb C; Shirasawa S; Rak JW; Coomber BL
Cancer Res; 2005 Sep; 65(18):8134-41. PubMed ID: 16166287
[TBL] [Abstract][Full Text] [Related]
42. A database to support the interpretation of human mismatch repair gene variants.
Ou J; Niessen RC; Vonk J; Westers H; Hofstra RM; Sijmons RH
Hum Mutat; 2008 Nov; 29(11):1337-41. PubMed ID: 18951442
[TBL] [Abstract][Full Text] [Related]
43. Conditional expression of mutated K-ras accelerates intestinal tumorigenesis in Msh2-deficient mice.
Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ
Oncogene; 2007 Jun; 26(30):4415-27. PubMed ID: 17297472
[TBL] [Abstract][Full Text] [Related]
44. Suppression of intestinal and mammary neoplasia by lifetime administration of aspirin in Apc(Min/+) and Apc(Min/+), Msh2(-/-) mice.
Sansom OJ; Stark LA; Dunlop MG; Clarke AR
Cancer Res; 2001 Oct; 61(19):7060-4. PubMed ID: 11585736
[TBL] [Abstract][Full Text] [Related]
45. Preservation of DNA integrity and neuronal degeneration.
Francisconi S; Codenotti M; Ferrari-Toninelli G; Uberti D; Memo M
Brain Res Brain Res Rev; 2005 Apr; 48(2):347-51. PubMed ID: 15850673
[TBL] [Abstract][Full Text] [Related]
46. Mismatch repair protein Msh2 contributes to UVB-induced cell cycle arrest in epidermal and cultured mouse keratinocytes.
van Oosten M; Stout GJ; Backendorf C; Rebel H; de Wind N; Darroudi F; van Kranen HJ; de Gruijl FR; Mullenders LH
DNA Repair (Amst); 2005 Jan; 4(1):81-9. PubMed ID: 15533840
[TBL] [Abstract][Full Text] [Related]
47. Mismatch repair genes identified using genetic screens in Blm-deficient embryonic stem cells.
Guo G; Wang W; Bradley A
Nature; 2004 Jun; 429(6994):891-5. PubMed ID: 15215866
[TBL] [Abstract][Full Text] [Related]
48. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA
Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706
[TBL] [Abstract][Full Text] [Related]
49. BRCA1 activates a G2-M cell cycle checkpoint following 6-thioguanine-induced DNA mismatch damage.
Yamane K; Schupp JE; Kinsella TJ
Cancer Res; 2007 Jul; 67(13):6286-92. PubMed ID: 17616687
[TBL] [Abstract][Full Text] [Related]
50. Medullary carcinoma of the pancreas in a man with hereditary nonpolyposis colorectal cancer due to a mutation of the MSH2 mismatch repair gene.
Banville N; Geraghty R; Fox E; Leahy DT; Green A; Keegan D; Geoghegan J; O'Donoghue D; Hyland J; Sheahan K
Hum Pathol; 2006 Nov; 37(11):1498-502. PubMed ID: 16996571
[TBL] [Abstract][Full Text] [Related]
51. Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice.
Reitmair AH; Redston M; Cai JC; Chuang TC; Bjerknes M; Cheng H; Hay K; Gallinger S; Bapat B; Mak TW
Cancer Res; 1996 Aug; 56(16):3842-9. PubMed ID: 8706033
[TBL] [Abstract][Full Text] [Related]
52. Role of the mismatch repair system and p53 in the clastogenicity and cytotoxicity induced by bleomycin.
Vernole P; Tedeschi B; Tentori L; Levati L; Argentin G; Cicchetti R; Forini O; Graziani G; D'Atri S
Mutat Res; 2006 Feb; 594(1-2):63-77. PubMed ID: 16139849
[TBL] [Abstract][Full Text] [Related]
53. Msh2 deficiency leads to chromosomal abnormalities, centrosome amplification, and telomere capping defect.
Campbell MR; Wang Y; Andrew SE; Liu Y
Oncogene; 2006 Apr; 25(17):2531-6. PubMed ID: 16331258
[TBL] [Abstract][Full Text] [Related]
54. Mismatch repair deficiency does not enhance ENU mutagenesis in the zebrafish germ line.
Feitsma H; de Bruijn E; van de Belt J; Nijman IJ; Cuppen E
Mutagenesis; 2008 Jul; 23(4):325-9. PubMed ID: 18469325
[TBL] [Abstract][Full Text] [Related]
55. Generation of a mouse mutant by oligonucleotide-mediated gene modification in ES cells.
Aarts M; Dekker M; de Vries S; van der Wal A; te Riele H
Nucleic Acids Res; 2006; 34(21):e147. PubMed ID: 17142234
[TBL] [Abstract][Full Text] [Related]
56. Compromised repair of clustered DNA damage in the human acute lymphoblastic leukemia MSH2-deficient NALM-6 cells.
Holt SM; Scemama JL; Panayiotidis MI; Georgakilas AG
Mutat Res; 2009 Mar; 674(1-2):123-30. PubMed ID: 18955159
[TBL] [Abstract][Full Text] [Related]
57. MSH2 missense mutations and HNPCC syndrome: pathogenicity assessment in a human expression system.
Belvederesi L; Bianchi F; Galizia E; Loretelli C; Bracci R; Catalani R; Amati M; Cellerino R
Hum Mutat; 2008 Nov; 29(11):E296-309. PubMed ID: 18781619
[TBL] [Abstract][Full Text] [Related]
58. The ability to engage enterocyte apoptosis does not predict long-term crypt survival in p53 and Msh2 deficient mice.
Sansom OJ; Clarke AR
Oncogene; 2002 Aug; 21(38):5934-9. PubMed ID: 12185594
[TBL] [Abstract][Full Text] [Related]
59. The associated contributions of p53 and the DNA mismatch repair protein Msh6 to spontaneous tumorigenesis.
Young LC; Keuling AM; Lai R; Nation PN; Tron VA; Andrew SE
Carcinogenesis; 2007 Oct; 28(10):2131-8. PubMed ID: 17615258
[TBL] [Abstract][Full Text] [Related]
60. Role of MUTYH and MSH2 in the control of oxidative DNA damage, genetic instability, and tumorigenesis.
Russo MT; De Luca G; Casorelli I; Degan P; Molatore S; Barone F; Mazzei F; Pannellini T; Musiani P; Bignami M
Cancer Res; 2009 May; 69(10):4372-9. PubMed ID: 19435918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]